See if a home diabetes screening kit helps people at risk for type 1 diabetes
Official title: Finding Immune Nascent Type 1 Diabetes (FIND T1D)
Run by Indiana University · NCT07663136 · Data updated 2026-11-12
This study tests whether email or mail outreach versus phone follow-up more effectively prompts Indiana Biobank participants to complete a Type 1 diabetes home screening kit.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Year to 99 Years |
| Sex | All |
| Enrollment | 3800 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Status | Recruiting |
| Started | July 28, 2026 |
| Main results expected | June 2029 |
| Study ends | June 2029 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT07663136 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Indiana Biobank participants who can consent and are aged 1–99 (including pregnant women) are potential candidates for the home screening portion.
✕Probably not a fit
Participants who refuse consent for home screening or have conditions excluding autoantibody screening may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers compare two recruitment approaches to see which yields higher completion of a Type 1 diabetes home screening kit among participants connected through the Indiana Biobank. The trial uses low-touch (email/mail) versus high-touch (phone contact and staff follow-up) communication methods. Participants in Indiana Biobank who consent can receive a home screening kit for Type 1 diabetes; eligibility includes broad age range (1–99) and pregnancy status, with exclusions for those who refuse consent for home screening or have active diabetes conditions that would preclude autoantibody screening. The study is led by Indiana University with collaboration from Sanofi and sites at Indiana University School of Medicine in Indianapolis. Interventions involve contacting participants by phone or email/mail to offer completion of the kit.
Why it matters
Potential benefit: If successful, the findings could guide more effective recruitment strategies to identify individuals at risk for Type 1 diabetes.
How similar studies have gone: Prior work supports that tailored recruitment approaches can influence participation rates, but this specific comparison of contact methods is novel in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant must be in Indiana Biobank * Participant must be able to provide consent * Ages 1-99 including pregnant women Exclusion Criteria: * Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study * While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening
Where it's running
-
Indiana University School of Medicine
Indianapolis, Indiana, United States Recruiting
Study contacts
- Study coordinator: Maureen Mullen Montagano
- Email: findt1d@iu.edu
- Phone: 317-274-7677
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oura Ring validation for sleep using gold-standard sleep tests
This study tests how well the Oura Ring matches the gold-standard sleep test ( PSG ) in healthy adults and people with sleep apnea.
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Cognitive Tasks and Models in a Large Online Sample
This study tests cognitive tasks and computational models in a large online group to see if these tools can help predict symptoms like hallucinations and delusions in the general population.
-
Single-dose study of DTI-117 given by injection in healthy adults
Researchers are testing a one-time dose of DTI-117 in healthy adult volunteers to see if it is safe and how it moves through the body.
-
Data-driven rural wellness interventions for vitality and endurance (DRIVE) pilot
This pilot test will see if personalized wellness coaching based on genomic, clinical, behavioral, and functional data can be feasibly delivered in a rural setting and improve cardiometabolic, cognitive, mental health, and functional outcomes over four months.
-
White potato meals and when you eat them: how timing changes blood sugar and appetite
This study tests how eating white potatoes with meals at different times affects blood sugar, hunger, and how much people eat later in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.